Cytosorbents Crp (CTSO) — Net Asset Quality Index
Cytosorbents Crp (CTSO) has a Net Asset Quality Index of -2.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $37.96 Million minus total liabilities of $38.71 Million yields net assets of $-751.00K. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Cytosorbents Crp for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cytosorbents Crp Net Asset Quality Index Over Time (2004–2025)
This chart shows how Cytosorbents Crp's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of June 2026, the index stands at -2.0%, representing net assets of $-751.00K against total assets of $37.96 Million USD. For live market cap and overall valuation, see Cytosorbents Crp (CTSO) market capitalisation.
Annual Net Asset Quality Index for Cytosorbents Crp (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for Cytosorbents Crp from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check CTSO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 13.4% | $5.90 Million | $44.18 Million | $38.28 Million | ▼ -10.1 pp |
| 2024 | 23.4% | $11.11 Million | $47.37 Million | $36.26 Million | ▼ -20.3 pp |
| 2023 | 43.7% | $23.28 Million | $53.26 Million | $29.99 Million | ▼ -12.2 pp |
| 2022 | 55.9% | $35.37 Million | $63.23 Million | $27.86 Million | ▼ -14.0 pp |
| 2021 | 69.9% | $62.58 Million | $89.52 Million | $26.94 Million | ▼ -18.2 pp |
| 2020 | 88.1% | $79.22 Million | $89.95 Million | $10.73 Million | ▲ +75.6 pp |
| 2019 | 12.5% | $3.42 Million | $27.38 Million | $23.96 Million | ▼ -39.2 pp |
| 2018 | 51.7% | $16.93 Million | $32.75 Million | $15.81 Million | ▲ +9.1 pp |
| 2017 | 42.6% | $10.26 Million | $24.10 Million | $13.84 Million | ▲ +47.5 pp |
| 2016 | -4.9% | $-474.09K | $9.69 Million | $10.17 Million | ▼ -77.8 pp |
| 2015 | 73.0% | $8.21 Million | $11.25 Million | $3.04 Million | ▲ +26.2 pp |
| 2014 | 46.8% | $3.96 Million | $8.47 Million | $4.51 Million | ▲ +399.4 pp |
| 2013 | -352.6% | $-14.27 Million | $4.05 Million | $18.31 Million | ▼ -4.5 pp |
| 2012 | -348.1% | $-11.63 Million | $3.34 Million | $14.96 Million | ▼ -363.1 pp |
| 2011 | 15.0% | $318.34K | $2.12 Million | $1.80 Million | ▲ +41.7 pp |
| 2010 | -26.7% | $-484.58K | $1.81 Million | $2.30 Million | ▼ -83.4 pp |
| 2009 | 56.6% | $1.27 Million | $2.24 Million | $970.76K | ▼ -13.0 pp |
| 2008 | 69.7% | $2.36 Million | $3.39 Million | $1.03 Million | ▲ +82.7 pp |
| 2007 | -13.0% | $-104.30K | $802.57K | $906.87K | ▼ -81.6 pp |
| 2006 | 68.6% | $2.36 Million | $3.45 Million | $1.08 Million | ▲ +504.1 pp |
| 2005 | -435.5% | $-82.93K | $19.04K | $101.97K | ▼ -235.5 pp |
| 2004 | -200.0% | $-60.00K | $30.00K | $90.00K | — |